Publications by authors named "Albrecht Neiss"

Claim this Profile
E
Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.
Ahmed Al-Chalabi, Edouard Matevossian, Anne-K V Thaden, Peter Luppa, Albrecht Neiss

BMC Gastroenterol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of measles vaccination on the incidence of otosclerosis in Germany.
Wolfgang Arnold, Raymonde Busch, Andreas Arnold, Björn Ritscher, Albrecht Neiss

Eur Arch Otorhinolaryngol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
Gerd Assmann, Heike Benecke, Albrecht Neiss, Paul Cullen, Helmut Schulte

Eur J Cardiovasc Prev Rehabil· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of varicella vaccination programmes: a review of the literature.
Thomas Hammerschmidt, Kurt Banz, Stefan Wagenpfeil, Albrecht Neiss, Peter Wutzler

Pharmacoeconomics· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of varicella in Germany. Potential risks and economic impact.
Kurt Banz, Stefan Wagenpfeil, Albrecht Neiss, Thomas Hammerschmidt, Peter Wutzler

Eur J Health Econ· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of health economic models: the example of EVITA.
Thomas Hammerschmidt, Anita Goertz, Stefan Wagenpfeil, Albrecht Neiss, Peter Wutzler

Value Health· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Alberto Zanchetti, M Gene Bond, Michael Hennig, Albrecht Neiss, Giuseppe Mancia

Circulation· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bootstrap confidence intervals for costs-of-illness of type 2 diabetes mellitus in Germany.
Stefan Wagenpfeil, Albrecht Neiss, Anita Goertz, Ursula Reitberger, Holger Stammer

Value Health· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Peter Wutzler, Albrecht Neiss, Kurt Banz, Anita Goertz, Helmtrud Bisanz

Med Microbiol Immunol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis